-
FDA Drug Approvals Q1 2025
10 Apr 2025 15:57 GMT
… clinical trials. The trials assessed … chikungunya vaccine, recombinant)– FDA approves recombinant vaccine … rilpivirine, and tenofovir alafenamide)– Indication for HIV treatment … treatment-resistant depression, or in conjunction with an oral antidepressant …
-
GSK Korea's long-acting HIV injection therapy gains insurance benefit
01 Apr 2025 08:18 GMT
… HIV-1 combination treatment, Vocabria (ingredient: cabotegravir 600mg) and Rekambys (ingredient: rilpivirine … SOLAR trial, a … medications.
Major reasons included freedom from daily pill … HIV unit. “Following our launch of Dovato, the first FDA-approved two-drug …
-
Actor and Comedian Kenan Thompson Teams Up with Phathom Pharmaceuticals to Raise Awareness About GERD and VOQUEZNA® (vonoprazan)
31 Mar 2025 11:59 GMT
… doctor about the condition. “Despite using over-the-counter medications and prescription treatments … a medicine that contains rilpivirine (EDURANT, COMPLERA, JULUCA, ODEFSEY) used to treat HIV … Pharmaceuticals at 1-888-775-PHAT (7428) or FDA at 1-800-FDA …
-
Is long-acting HIV treatment as good as taking daily pills?
30 Mar 2025 13:51 GMT
… HIV treatment as good as taking daily pills?
Treatment … HIV virus developing resistance against HIV medicine, also referred to as drug … Chairperson of German AIDS Society, and … injectable HIV treatment regimens of cabotegravir and rilpivirine (intramuscular …
-
Broadly Neutralizing Antibodies Show Promise for Long-Acting HIV Treatment
24 Mar 2025 13:12 GMT
… HIV, researchers reported results from a small Phase I trial … no severe drug-related adverse events, serious treatment-emergent … N6LS. Injectable cabotegravir and rilpivirine (Cabenuva), administered by … , an enzyme that aids absorption and enables higher …
-
A jab that could protect against HIV for a year at a time
22 Mar 2025 17:00 GMT
… the PURPOSE 1 trial, which was conducted … 23 received another HIV prevention pill containing emtricitabine and tenofovir … of the drugs cabotegravir and rilpivirine for HIV treatment has been … Medicine and director of the Yale Aids Programme clinical trials unit …
-
Expanded Use of Long-Acting Injectables for HIV and HIV Prevention
20 Mar 2025 17:26 GMT
… , the guidelines recommend drug resistance testing.
CAB … 5 phase 3 trials (the PURPOSE trials) ongoing for … of Medicine.
The results of the PURPOSE 2 trial (NCT04925752 … treatment recommendation on use of cabotegravir and rilpivirine for people with HIV …
-
HIV Drugs Market Outlook: Future Trends Indicate a US$ 47.5 Billion Industry by 2034 with a Shift Toward Single-dose Regimens | Report by TMR
18 Mar 2025 11:28 GMT
… HIV treatment
Teva Pharmaceutical Industries Ltd.
Generic ARVs, Lamivudine, Zidovudine
Growth in cos
HIV Drugs … : Recent FDA approvals, such as ViiV Healthcare’s Cabenuva (cabotegravir, rilpivirine) in …
-
Broadly neutralising antibody N6LS could be part of long-acting HIV treatment
17 Mar 2025 16:04 GMT
… . Injectable cabotegravir and rilpivirine, administered by injection … In pharmacology, a medication which maintains its … trials, to defend humans against HIV infection, treat HIV … HIV prevention, treatment and cure research. As with antiretroviral drugs …
-
Zero Cases of HIV Acquisition Seen for Apretude, Cabenuva Treatment
14 Mar 2025 21:51 GMT
… data on cabotegravir plus rilpivirine long-acting (CAB+RPV … , MD, MPH, chief medical officer at ViiV Healthcare, said … HIV treatment and prevention, that remove the need for daily pills.” … intravenous drug and 88% receiving the subcutaneous drug maintained HIV …